Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Use of Botulinum Toxin in Spasticity Post Stroke. (EUBoSS)

This study has been completed.
Keele University
Stroke Research Network
Information provided by (Responsible Party):
Cameron Lindsay, Sandwell & West Birmingham Hospitals NHS Trust Identifier:
First received: June 18, 2013
Last updated: November 17, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)